Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments; Reopening of the Comment Period
NonrulemakingNoticeFDA-2026-N-0809-0040
Comments
0
Awaiting comments
Deadline
Closed on Mar 4, 2026
Closed Mar 4, 2026
Net supportiSupport minus oppose · campaigns included
—
Document
Details
The document's own metadata, straight from regulations.gov.
- Posted
- Jun 11, 2026
- Comment period
- Jun 11, 2026 – Mar 4, 2026
- Agency
- Food and Drug Administration (FDA)
- FR Doc
- 2026-11690
Analysis
Overview
No comments yet.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
No comments match.